Mortality and Treatment Modality of End-Stage Renal Disease
Authors: Gerald Schulman
Journal: Annals of Internal Medicine (2005)

Editorials2 August 2005Mortality and Treatment Modality of End-Stage Renal DiseaseGerald Schulman, MDGerald Schulman, MDFrom Vanderbilt University School of Medicine, Nashville, TN 37232.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-143-3-200508020-00010 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Between the conceptionAnd the creationBetween the emotionAnd the responseFalls the Shadow–T.S. EliotIn this issue, Jaar and colleagues (1) report the survival of patients with end-stage renal disease (ESRD) who are treated with either hemodialysis or peritoneal dialysis. For up to 7 years, the authors followed 1041 patients who were beginning dialysis, 767 patients receiving hemodialysis, and 274 patients receiving peritoneal dialysis. They conclude that after 2 years of dialysis, the risk for death of patients treated with peritoneal dialysis was twice that of patients treated with hemodialysis. The findings of Jaar and colleagues' study differ from those of similar ...References1. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med. 2005;143:174-83. LinkGoogle Scholar2. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:177-83. [PMID: 7579082] CrossrefMedlineGoogle Scholar3. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int. 1994;45:1163-9. [PMID: 8007587] CrossrefMedlineGoogle Scholar4. Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis. 1997;30:334-42. [PMID: 9292560] CrossrefMedlineGoogle Scholar5. Foley RN, Parfrey PS, Harnett JD, Kent GM, O'Dea R, Murray DC, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9:267-76. [PMID: 9527403] CrossrefMedlineGoogle Scholar6. Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065-74. [PMID: 10585316] CrossrefMedlineGoogle Scholar7. Xue JL, Everson SE, Constantini EG, Ebben JP, Chen SC, Agodoa LY, et al. Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. Kidney Int. 2002;61:741-6. [PMID: 11849418] CrossrefMedlineGoogle Scholar8. Tanna MM, Vonesh EF, Korbet SM. Patient survival among incident peritoneal dialysis and hemodialysis patients in an urban setting. Am J Kidney Dis. 2000;36:1175-82. [PMID: 11096042] CrossrefMedlineGoogle Scholar9. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol. 2001;12:2411-7. [PMID: 11675417] CrossrefMedlineGoogle Scholar10. Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl. 1993;40:S106-10. [PMID: 8445831] MedlineGoogle Scholar11. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158-62. [PMID: 11562415] CrossrefMedlineGoogle Scholar12. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999;33:523-34. [PMID: 10070917] CrossrefMedlineGoogle Scholar13. Xue JL, Chen SC, Ebben JP, Constantini EG, Everson SE, Frazier ET, et al. Peritoneal and hemodialysis: I. Differences in patient characteristics at initiation. Kidney Int. 2002;61:734-40. [PMID: 11849417] CrossrefMedlineGoogle Scholar14. Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant. 1998;13:962-8. [PMID: 9568858] CrossrefMedlineGoogle Scholar15. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Pagé D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1998;9:1285-92. [PMID: 9644640] CrossrefMedlineGoogle Scholar16. Cueto-Manzano AM, Correa-Rotter R. Is high peritoneal transport rate an independent risk factor for CAPD mortality? Kidney Int. 2000;57:314-20. [PMID: 10620214] CrossrefMedlineGoogle Scholar17. Blake PG. What is the problem with high transporters? [Editorial] Perit Dial Int. 1997;17:317-20. [PMID: 9284454] CrossrefMedlineGoogle Scholar18. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med. 1981;305:1176-81. [PMID: 7027040] CrossrefMedlineGoogle Scholar19. NKF-DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. National Kidney Foundation. Am J Kidney Dis. 2000;37 Suppl 1 S7-64. Google Scholar20. Schulman G. The dose of dialysis in hemodialysis patients: impact on nutrition. Semin Dial. 2004;17:479-88. [PMID: 15660579] CrossrefMedlineGoogle Scholar21. Chatoth DK, Golper TA, Gokal R. Morbidity and mortality in redefining adequacy of peritoneal dialysis: a step beyond the National Kidney Foundation Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1999;33:617-32. [PMID: 10196002] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Gerald Schulman, MDAffiliations: From Vanderbilt University School of Medicine, Nashville, TN 37232.Disclosures: None disclosed.Corresponding Author: Gerald Schulman, MD, Vanderbilt University School of Medicine, S3223 Medical Center North, Vanderbilt University Medical Center, Nashville, TN 37232; e-mail, gerald.schulman@vanderbilt.edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoComparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Bernard G. Jaar , Josef Coresh , Laura C. Plantinga , Nancy E. Fink , Michael J. Klag , Andrew S. Levey , Nathan W. Levin , John H. Sadler , Alan Kliger , and Neil R. Powe Metrics Cited byMulticenter Investigation of the Initial Hemodialysis Vascular Access and Its Related Factors in Hangzhou of ChinaSurvival by Dialysis Modality—Who Cares?Dialysis outcomes in Colombia (DOC) study: A comparison of patient survival on peritoneal dialysis vs hemodialysis in ColombiaChildren on Long-Term Dialysis in the United States: Findings From the 2005 ESRD Clinical Performance Measures ProjectQuality of Life Assessments in Hemodialysis and Peritoneal Dialysis Patients: An Important Dimension of Patient Choice: Why Is the Evidence Favoring Hemodialysis over Peritoneal Dialysis Misleading?The Choice StudyWorshipping at the Altar of St. Cox: WHO Adjusts the Adjustments?Modality options for renal replacement therapy: The integrated care concept revisited 2 August 2005Volume 143, Issue 3Page: 229-231KeywordsForecastingIntent to treat analysisMedical dialysisPatientsPeritoneal dialysisPhosphorusRenal failureRenal systemRisk managementUrea ePublished: 2 August 2005 Issue Published: 2 August 2005 Copyright & PermissionsCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...